All Posts By

Julian Schloßmacher

Drug Master File – Count Down

By | Blog | No Comments

Drug master file - Count down

The FDA deadline on NDA, ANDA, BLA and DMF (paper submissions) is less than 4 weeks away. By 5th of May 2017 the FDA requires that all DMFs are to be submitted in the eCTD format via the Electronic Submissions Gateway (ESG). If your DMF is in paper format with FDA, the same submission does not need to be resubmitted in eCTD format. However, as you move forward it is important to make sure your documents are properly prepared (bookmarked, OCR’d, proper orientation) and you can create your baseline DMF submission as eCTD. The DMF in eCTD format mandate applies to amendments, letters of authorization and annual reports. Read More

SPOR – Key Activities For The Industry (EMA-Update)

By | Blog | No Comments

On August 4, 2016, The European Medicines Agency (EMA) hosted a webinar for the industry to further the understanding of the substance, product, organization and referential (SPOR) data services and related impacts. The European Commission, the European Union (EU) Network Data Board and the EU ISO IDMP Task Force have endorsed a phased implementation of the ISO IDMP standards. This approach will allow lessons learned during each phase to be applied to subsequent phases, processes and systems to mature over time and stakeholders to gain an understanding prior to the full roll out. Read More